Return On Assets of Allogene Therapeutics, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Allogene Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Allogene Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -43%, a 6.3% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Return On Assets for 2024 was -43%, a 4.4% increase from 2023.
  • Allogene Therapeutics, Inc. annual Return On Assets for 2023 was -45%, a 22% decline from 2022.
  • Allogene Therapeutics, Inc. annual Return On Assets for 2022 was -37%, a 127% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Allogene Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -43% +2.9% +6.3% 01 Jul 2025 30 Sep 2025
Q2 2025 -45% -1.6% -3.7% 01 Apr 2025 30 Jun 2025
Q1 2025 -44% -0.97% -2.3% 01 Jan 2025 31 Mar 2025
Q4 2024 -43% +2% +4.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -46% -1.7% -3.8% 01 Jul 2024 30 Sep 2024
Q2 2024 -43% +1.4% +3.1% 01 Apr 2024 30 Jun 2024
Q1 2024 -43% -0.76% -1.8% 01 Jan 2024 31 Mar 2024
Q4 2023 -45% -8.2% -22% 01 Oct 2023 31 Dec 2023
Q3 2023 -44% -19% -77% 01 Jul 2023 30 Sep 2023
Q2 2023 -45% -21% -91% 01 Apr 2023 30 Jun 2023
Q1 2023 -42% -21% -97% 01 Jan 2023 31 Mar 2023
Q4 2022 -37% -21% -127% 01 Oct 2022 31 Dec 2022
Q3 2022 -25% +2.4% +8.8% 01 Jul 2022 30 Sep 2022
Q2 2022 -23% +2.3% +9% 01 Apr 2022 30 Jun 2022
Q1 2022 -22% +2.6% +11% 01 Jan 2022 31 Mar 2022
Q4 2021 -16% +12% +43% 01 Oct 2021 31 Dec 2021
Q3 2021 -27% -2.5% -10% 01 Jul 2021 30 Sep 2021
Q2 2021 -26% +1.4% +5.2% 01 Apr 2021 30 Jun 2021
Q1 2021 -24% +5.1% +18% 01 Jan 2021 31 Mar 2021
Q4 2020 -29% -3.3% -13% 01 Oct 2020 31 Dec 2020
Q3 2020 -25% -4.1% -20% 01 Jul 2020 30 Sep 2020
Q2 2020 -27% -5.2% -24% 01 Apr 2020 30 Jun 2020
Q1 2020 -29% 01 Jan 2020 31 Mar 2020
Q4 2019 -25% 01 Oct 2019 31 Dec 2019
Q3 2019 -21% 01 Jul 2019 30 Sep 2019
Q2 2019 -22% 01 Apr 2019 30 Jun 2019

Allogene Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -43% +2% +4.4% 01 Jan 2024 31 Dec 2024
2023 -45% -8.2% -22% 01 Jan 2023 31 Dec 2023
2022 -37% -21% -127% 01 Jan 2022 31 Dec 2022
2021 -16% +12% +43% 01 Jan 2021 31 Dec 2021
2020 -29% -3.3% -13% 01 Jan 2020 31 Dec 2020
2019 -25% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.